Creation and testing of new economic models
- WP2: Antibiotic R&D pipeline simulation results. Effects of different intervention mechanisms
- Push incentives to stimulate research and development of new antibiotics
- Designing a delinked incentive for critical antibiotics – lessons from Norway
- Antibiotics as controlled medicines? Lessons from the Single Convention on Narcotics
- An approach to designing market entry rewards for stimulating antibiotic development
- Solutions to incentivize antibiotics R&D – No “one-size-fits-all”
Responsible use of antibiotics, new and old
- What is responsible antibiotic use? Towards a global definition
- Barriers and facilitators of responsible systemic antibiotic use from the patient’s perspective: a systematic review
- Views and experiences of currently or recently hospitalized patients in four European countries with regard to barriers and facilitators to responsible antibiotic use: a qualitative descriptive study
- Quantity metrics assessing antibiotic use in the outpatient setting: a global consensus procedure
Back to Conference Downloads and Resources.